AU
CA
NZ
UK
US
IND
Last update at 2026-03-10T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
1 Growth Stock with All-Star Potential and 2 to Avoid
Mon 26 May 25, 04:31 AMIs Option Care Health (OPCH) the Best Performing Healthcare Stock to Buy Now?
Sun 11 May 25, 09:16 PM1 Cash-Producing Stock to Keep an Eye On and 2 to Keep Off Your Radar
Thu 08 May 25, 04:35 AMAdaptHealth (AHCO) To Report Earnings Tomorrow: Here Is What To Expect
Mon 05 May 25, 07:04 AMBrookdale (BKD) To Report Earnings Tomorrow: Here Is What To Expect
Mon 05 May 25, 07:04 AMThe Pennant Group (PNTG) Q1 Earnings Report Preview: What To Look For
Mon 05 May 25, 07:04 AM2 Healthcare Stocks to Research Further and 1 to Be Wary Of
Mon 05 May 25, 04:35 AMAddus HomeCare (ADUS) Reports Earnings Tomorrow: What To Expect
Sun 04 May 25, 07:04 AMOption Care (OPCH) is an Incredible Growth Stock: 3 Reasons Why
Fri 02 May 25, 04:45 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 205.77M | 116.49M | -5.24300M | -78.19400M | -51.02400M |
| Minority interest | - | - | - | - | - |
| Net income | 150.56M | 139.90M | -8.07600M | -75.92000M | -51.69300M |
| Selling general administrative | 566.12M | 525.71M | 500.20M | 459.63M | 47.26M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 866.92M | 779.61M | 682.26M | 513.00M | 243.04M |
| Reconciled depreciation | 65.43M | 68.80M | 77.90M | 57.87M | 23.60M |
| Ebit | 240.23M | 190.84M | 110.75M | -4.47000M | 17.36M |
| Ebitda | 325.01M | 252.30M | 180.42M | 53.40M | 40.96M |
| Depreciation and amortization | 84.78M | 61.46M | 69.67M | 57.87M | 23.60M |
| Non operating income net other | - | - | - | - | -4.49400M |
| Operating income | 240.23M | 190.84M | 110.75M | -4.47000M | -51.59200M |
| Other operating expenses | 3704.50M | 3247.80M | 2921.86M | 2310.74M | 691.54M |
| Interest expense | 53.81M | 67.00M | 107.77M | 73.72M | 57.43M |
| Tax provision | 55.21M | -23.40400M | 2.83M | -2.27400M | 0.57M |
| Interest income | - | - | - | 73.18M | 57.43M |
| Net interest income | -53.80600M | -67.00300M | -107.77000M | -73.72400M | -57.43300M |
| Extraordinary items | - | - | - | - | -0.10100M |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 55.21M | -23.40400M | 2.83M | -2.27400M | 0.57M |
| Total revenue | 3944.74M | 3438.64M | 3032.61M | 2310.42M | 708.90M |
| Total operating expenses | 626.69M | 588.76M | 571.51M | 513.32M | 225.68M |
| Cost of revenue | 3077.82M | 2659.03M | 2350.35M | 1797.42M | 465.87M |
| Total other income expense net | -34.46300M | -74.34700M | -115.99800M | -73.72400M | -10.95100M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 150.56M | 139.90M | -8.07600M | -75.92000M | -51.59200M |
| Net income applicable to common shares | 150.56M | 139.90M | -8.07600M | -75.92000M | -62.90300M |
| Preferred stock and other adjustments | - | - | - | - | 11.21M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 3328.35M | 3112.94M | 2790.92M | 2647.44M | 2589.55M |
| Intangible assets | 335.40M | 364.12M | 366.02M | 351.05M | 385.91M |
| Earning assets | - | - | - | - | - |
| Other current assets | 46.24M | 98.33M | 69.50M | 70.81M | 51.31M |
| Total liab | 1906.68M | 1726.83M | 1615.03M | 1631.71M | 1682.72M |
| Total stockholder equity | 1421.67M | 1386.10M | 1175.89M | 1015.72M | 906.83M |
| Deferred long term liab | - | 22.15M | - | 3.34M | 2.14M |
| Other current liab | 167.52M | 139.05M | 180.45M | 151.11M | 108.94M |
| Common stock | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M |
| Capital stock | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M |
| Retained earnings | 457.51M | 190.42M | 39.87M | -100.03100M | -91.95500M |
| Other liab | - | 31.84M | 95.44M | 11.81M | 11.22M |
| Good will | 1540.25M | 1533.42M | 1477.56M | 1428.61M | 1425.54M |
| Other assets | 0.00000M | 20.91M | 470.13M | 89.62M | 5.74M |
| Cash | 343.85M | 294.19M | 119.42M | 99.27M | 67.06M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 618.31M | 565.35M | 459.69M | 434.02M | 330.00M |
| Current deferred revenue | - | 22.15M | -25.08900M | -28.13600M | -29.64100M |
| Net debt | 822.56M | 789.40M | 940.48M | 1015.84M | 1210.19M |
| Short term debt | 24.28M | 25.38M | 25.09M | 28.14M | 29.64M |
| Short long term debt | 6.00M | 6.00M | 6.00M | 9.25M | 9.25M |
| Short long term debt total | 1166.41M | 1083.58M | 1059.90M | 1115.10M | 1277.25M |
| Other stockholder equity | 949.16M | 1174.50M | 1136.45M | 1126.91M | 1005.96M |
| Property plant equipment | - | 108.32M | 111.53M | 121.15M | 133.20M |
| Total current assets | 1094.26M | 994.34M | 710.26M | 657.01M | 558.65M |
| Long term investments | - | - | - | - | 17.00M |
| Net tangible assets | - | -489.06500M | -646.26500M | -763.93800M | -904.62500M |
| Short term investments | 9.75M | - | - | - | - |
| Net receivables | 430.16M | 377.54M | 338.24M | 328.34M | 324.42M |
| Long term debt | 1056.65M | 1058.20M | 1059.90M | 1115.10M | 1277.25M |
| Inventory | 274.00M | 224.28M | 183.09M | 158.60M | 115.88M |
| Accounts payable | 426.51M | 378.76M | 279.25M | 282.91M | 221.06M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 14.98M | 21.16M | -0.45100M | -11.17200M | -7.19500M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | 0.02M | 0.02M | 0.02M | 0.02M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | 190.42M | 39.87M | -100.03100M | -91.95500M |
| Treasury stock | - | - | -2.40300M | -2.40300M | -2.40300M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 11.27M | 90.58M | 125.54M | 89.62M | 86.24M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 2234.10M | 2118.60M | 2080.66M | 1990.43M | 2030.89M |
| Capital lease obligations | 103.76M | 90.82M | 93.58M | 89.66M | 78.63M |
| Long term debt total | - | 1058.20M | 1059.90M | 1115.10M | 1277.25M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -108.05200M | -111.54100M | -26.33400M | -727.82600M | 2.91M |
| Change to liabilities | 101.65M | 31.98M | 95.16M | -28.50200M | 0.25M |
| Total cashflows from investing activities | -108.05200M | -111.54100M | -26.33400M | -727.82600M | -13.51500M |
| Net borrowings | -6.00000M | -76.83800M | -186.87900M | 720.22M | 8.13M |
| Total cash from financing activities | 15.27M | -76.87000M | -68.84900M | 719.02M | 8.07M |
| Change to operating activities | -50.76300M | 25.98M | -5.43600M | -22.55000M | -10.72700M |
| Net income | 150.56M | 139.90M | -8.07600M | -75.92000M | -51.59200M |
| Change in cash | 174.76M | 20.16M | 32.21M | 30.66M | -25.54700M |
| Begin period cash flow | 119.42M | 99.27M | 67.06M | 36.39M | 44.41M |
| End period cash flow | 294.19M | 119.42M | 99.27M | 67.06M | 18.86M |
| Total cash from operating activities | 267.55M | 208.57M | 127.39M | 39.47M | -20.10400M |
| Issuance of capital stock | 0.00000M | 0.00000M | 118.93M | - | 0.00000M |
| Depreciation | 65.43M | 68.80M | 77.90M | 57.87M | 23.60M |
| Other cashflows from investing activities | -72.69400M | -85.90900M | 0.54M | -699.53400M | 0.36M |
| Dividends paid | - | - | - | 2.00M | - |
| Change to inventory | -41.01000M | -22.70000M | -42.72500M | -12.85300M | 11.36M |
| Change to account receivables | -36.88900M | -4.27300M | -3.92400M | 82.28M | -29.34200M |
| Sale purchase of stock | 20.92M | - | 118.93M | -4.50100M | -0.05500M |
| Other cashflows from financing activities | 21.27M | 833.48M | -13.78300M | 947.76M | 9.95M |
| Change to netincome | 57.32M | -8.92900M | 22.36M | 17.33M | 16.76M |
| Capital expenditures | 35.36M | 25.63M | 26.88M | 28.29M | 13.88M |
| Change receivables | -36.88900M | -4.27300M | -3.92400M | 82.28M | -29.34200M |
| Cash flows other operating | -33.81500M | -1.20800M | -18.81900M | -5.24700M | -50.90000M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | 174.76M | 20.16M | 32.21M | 30.66M | -25.54700M |
| Change in working capital | -29.77700M | -11.37000M | 7.13M | 38.58M | -16.70600M |
| Stock based compensation | 16.78M | 9.57M | 2.92M | 4.17M | 4.17M |
| Other non cash items | 15.36M | 32.03M | 46.33M | 19.38M | 20.35M |
| Free cash flow | 232.19M | 182.94M | 100.52M | 11.18M | -33.97900M |
Sector: Healthcare Industry: Medical Care Facilities
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| OPCH Option Care Health Inc |
-0.06 0.20% | 29.61 | 18.95 | 27.93 | 1.23 | 3.72 | 1.42 | 12.94 |
| HCA HCA Holdings Inc |
-7.49 1.37% | 537.64 | 13.19 | 13.66 | 1.13 | 293.44 | 1.77 | 8.22 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.05 0.36% | 14.02 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| FSNUF Fresenius SE & Co. KGaA |
- -% | 54.35 | 16.76 | 9.62 | 0.42 | 0.79 | 0.78 | 5.31 |
| JDHIY JD Health International Inc |
- -% | 9.08 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
3000 Lakeside Drive, Bannockburn, IL, United States, 60015
| Name | Title | Year Born |
|---|---|---|
| Mr. John C. Rademacher | CEO, Pres & Director | 1967 |
| Mr. Michael H. Shapiro | CFO & Sr. VP | 1971 |
| Mr. Richard P. Denness | Chief Commercial Officer | 1967 |
| Mr. Brett Michalak | Chief Information Officer | NA |
| Mr. Collin G. Smyser | Gen. Counsel & Corp. Sec. | NA |
| Ms. Caroline Budde | Sr. VP & Chief Compliance Officer | NA |
| Mr. Mike Bavaro | Chief HR & Diversity Officer | NA |
| Mr. Matthew Deans | Sr. VP of Bus. Devel. | NA |
| Mr. Christopher Frederick Hartman | Chief Growth Officer | 1967 |
| Ms. Julie Koenig | Sr. VP of Operations | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...